| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.51 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.04 |